ArticleInternational journal of hematology2022

Predictive value of clinical examination parameters for cardiovascular adverse events during treatment of chronic myeloid leukemia with tyrosine kinase inhibitors.

Mika Nakamae et al.PubMed ↗Publisher ↗

No numbers read from the abstract.